BioAge Labs, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BIOA | AMLX | BCRX | NBIX | MAZE | ALEC | |
|---|---|---|---|---|---|---|
| Market cap | 272.63M | 3.45B | 2.14B | 14.37B | 1.54B | 232.25M |
| P/E (TTM) | — | — | — | 20.6 | — | — |
| Forward P/E | -2.4 | -23.9 | 8.9 | 11.8 | -8.6 | -2.8 |
| Price/book | 0.7 | 12.8 | -4.7 | 3.9 | 3.4 | -23.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +7.80% | +93.66% | +30.22% | +3.02% | −2.81% | −30.43% |
| Today | −6.31% | −2.35% | −2.22% | −0.75% | +2.18% | 0.00% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All BIOA news ›BioAge Labs, Inc. (NASDAQ:BIOA) Stock Has Average Price Target of $36.57
Posted by Kim Johansen on Oct 1st, 2026 View Our Latest Report on BioAge Labs BioAge Labs, Inc (NASDAQ:BIOA) is a clinical-stage biotechnology company focused on developing medicines that target the biological mechanisms of aging. Its…
From articles in the 4Search news index.
In the news
Mentioned with
Themes
Most coverage from
-
themarketsdaily.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.